nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—duodenum cancer	0.182	0.182	CbGpPWpGaD
Promazine—DRD1—G alpha (s) signalling events—SCT—duodenum cancer	0.0179	0.0179	CbGpPWpGaD
Promazine—CHRM5—G alpha (q) signalling events—GAST—duodenum cancer	0.0142	0.0142	CbGpPWpGaD
Promazine—ADRA1D—G alpha (q) signalling events—GAST—duodenum cancer	0.0134	0.0134	CbGpPWpGaD
Promazine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0127	0.0127	CbGpPWpGaD
Promazine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.012	0.012	CbGpPWpGaD
Promazine—HTR2C—G alpha (q) signalling events—GAST—duodenum cancer	0.0116	0.0116	CbGpPWpGaD
Promazine—ADRA1B—G alpha (q) signalling events—GAST—duodenum cancer	0.0111	0.0111	CbGpPWpGaD
Promazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0104	0.0104	CbGpPWpGaD
Promazine—HTR2A—G alpha (q) signalling events—GAST—duodenum cancer	0.0101	0.0101	CbGpPWpGaD
Promazine—HRH1—G alpha (q) signalling events—GAST—duodenum cancer	0.0101	0.0101	CbGpPWpGaD
Promazine—CHRM1—G alpha (q) signalling events—GAST—duodenum cancer	0.01	0.01	CbGpPWpGaD
Promazine—CHRM3—G alpha (q) signalling events—GAST—duodenum cancer	0.00999	0.00999	CbGpPWpGaD
Promazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00993	0.00993	CbGpPWpGaD
Promazine—ADRA1A—G alpha (q) signalling events—GAST—duodenum cancer	0.00987	0.00987	CbGpPWpGaD
Promazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00901	0.00901	CbGpPWpGaD
Promazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00899	0.00899	CbGpPWpGaD
Promazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00896	0.00896	CbGpPWpGaD
Promazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00893	0.00893	CbGpPWpGaD
Promazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00882	0.00882	CbGpPWpGaD
Promazine—DRD4—G alpha (i) signalling events—SST—duodenum cancer	0.0086	0.0086	CbGpPWpGaD
Promazine—CHRM4—G alpha (i) signalling events—SST—duodenum cancer	0.00848	0.00848	CbGpPWpGaD
Promazine—HTR2A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00798	0.00798	CbGpPWpGaD
Promazine—CHRM2—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00784	0.00784	CbGpPWpGaD
Promazine—DRD4—GPCR ligand binding—SCT—duodenum cancer	0.0072	0.0072	CbGpPWpGaD
Promazine—CHRM4—GPCR ligand binding—SCT—duodenum cancer	0.00711	0.00711	CbGpPWpGaD
Promazine—DRD4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00684	0.00684	CbGpPWpGaD
Promazine—CHRM5—GPCR ligand binding—SCT—duodenum cancer	0.0068	0.0068	CbGpPWpGaD
Promazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00675	0.00675	CbGpPWpGaD
Promazine—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.00648	0.00648	CbGpPWpGaD
Promazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00646	0.00646	CbGpPWpGaD
Promazine—ADRA1D—GPCR ligand binding—SCT—duodenum cancer	0.0064	0.0064	CbGpPWpGaD
Promazine—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00616	0.00616	CbGpPWpGaD
Promazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00607	0.00607	CbGpPWpGaD
Promazine—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.00585	0.00585	CbGpPWpGaD
Promazine—CHRM2—G alpha (i) signalling events—SST—duodenum cancer	0.00565	0.00565	CbGpPWpGaD
Promazine—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.00555	0.00555	CbGpPWpGaD
Promazine—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00531	0.00531	CbGpPWpGaD
Promazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00527	0.00527	CbGpPWpGaD
Promazine—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00523	0.00523	CbGpPWpGaD
Promazine—DRD4—GPCR ligand binding—SST—duodenum cancer	0.00521	0.00521	CbGpPWpGaD
Promazine—CHRM4—GPCR ligand binding—SST—duodenum cancer	0.00514	0.00514	CbGpPWpGaD
Promazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00504	0.00504	CbGpPWpGaD
Promazine—CHRM5—GPCR ligand binding—SST—duodenum cancer	0.00492	0.00492	CbGpPWpGaD
Promazine—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.0049	0.0049	CbGpPWpGaD
Promazine—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00482	0.00482	CbGpPWpGaD
Promazine—HRH1—GPCR ligand binding—SCT—duodenum cancer	0.00481	0.00481	CbGpPWpGaD
Promazine—CHRM1—GPCR ligand binding—SCT—duodenum cancer	0.00479	0.00479	CbGpPWpGaD
Promazine—CHRM3—GPCR ligand binding—SCT—duodenum cancer	0.00478	0.00478	CbGpPWpGaD
Promazine—CHRM2—GPCR ligand binding—SCT—duodenum cancer	0.00473	0.00473	CbGpPWpGaD
Promazine—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.00472	0.00472	CbGpPWpGaD
Promazine—DRD1—GPCR ligand binding—SST—duodenum cancer	0.00469	0.00469	CbGpPWpGaD
Promazine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00465	0.00465	CbGpPWpGaD
Promazine—ADRA1D—GPCR ligand binding—SST—duodenum cancer	0.00463	0.00463	CbGpPWpGaD
Promazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00457	0.00457	CbGpPWpGaD
Promazine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00456	0.00456	CbGpPWpGaD
Promazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00455	0.00455	CbGpPWpGaD
Promazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00453	0.00453	CbGpPWpGaD
Promazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00449	0.00449	CbGpPWpGaD
Promazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00448	0.00448	CbGpPWpGaD
Promazine—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.00438	0.00438	CbGpPWpGaD
Promazine—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00429	0.00429	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—GAST—duodenum cancer	0.00424	0.00424	CbGpPWpGaD
Promazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00416	0.00416	CbGpPWpGaD
Promazine—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.00407	0.00407	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—GAST—duodenum cancer	0.00406	0.00406	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—SCT—duodenum cancer	0.00402	0.00402	CbGpPWpGaD
Promazine—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00401	0.00401	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.0039	0.0039	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.00387	0.00387	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—GAST—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—SCT—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Promazine—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.00384	0.00384	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—GAST—duodenum cancer	0.00381	0.00381	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.0037	0.0037	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—GAST—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00366	0.00366	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—SCT—duodenum cancer	0.00365	0.00365	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—SCT—duodenum cancer	0.00362	0.00362	CbGpPWpGaD
Promazine—DRD2—GPCR ligand binding—SST—duodenum cancer	0.00354	0.00354	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00351	0.00351	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—SCT—duodenum cancer	0.00349	0.00349	CbGpPWpGaD
Promazine—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Promazine—HRH1—GPCR ligand binding—SST—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Promazine—CHRM1—GPCR ligand binding—SST—duodenum cancer	0.00346	0.00346	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—GAST—duodenum cancer	0.00346	0.00346	CbGpPWpGaD
Promazine—CHRM3—GPCR ligand binding—SST—duodenum cancer	0.00345	0.00345	CbGpPWpGaD
Promazine—CHRM2—GPCR ligand binding—SST—duodenum cancer	0.00342	0.00342	CbGpPWpGaD
Promazine—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00341	0.00341	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.00333	0.00333	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—SCT—duodenum cancer	0.00328	0.00328	CbGpPWpGaD
Promazine—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00317	0.00317	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00317	0.00317	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.00313	0.00313	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.003	0.003	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.003	0.003	CbGpPWpGaD
Promazine—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.00294	0.00294	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.00292	0.00292	CbGpPWpGaD
Promazine—CHRM4—GPCR downstream signaling—SST—duodenum cancer	0.0029	0.0029	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00287	0.00287	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00287	0.00287	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—GAST—duodenum cancer	0.00287	0.00287	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—GAST—duodenum cancer	0.00286	0.00286	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—GAST—duodenum cancer	0.00285	0.00285	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00285	0.00285	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—GAST—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—SST—duodenum cancer	0.00278	0.00278	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00273	0.00273	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00272	0.00272	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—SCT—duodenum cancer	0.00272	0.00272	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—SCT—duodenum cancer	0.00271	0.00271	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—SCT—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—SCT—duodenum cancer	0.00267	0.00267	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00267	0.00267	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.00267	0.00267	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.00265	0.00265	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.00265	0.00265	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—SST—duodenum cancer	0.00264	0.00264	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—SST—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—GAST—duodenum cancer	0.0026	0.0026	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—GAST—duodenum cancer	0.00259	0.00259	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—GAST—duodenum cancer	0.00259	0.00259	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—GAST—duodenum cancer	0.00256	0.00256	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.00255	0.00255	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—SST—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00251	0.00251	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00248	0.00248	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00247	0.00247	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—SCT—duodenum cancer	0.00247	0.00247	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—SCT—duodenum cancer	0.00246	0.00246	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—SCT—duodenum cancer	0.00245	0.00245	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—SCT—duodenum cancer	0.00243	0.00243	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00242	0.00242	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00241	0.00241	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—SST—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—GAST—duodenum cancer	0.0023	0.0023	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—GAST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00225	0.00225	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00218	0.00218	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—GAST—duodenum cancer	0.00218	0.00218	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.00217	0.00217	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—SCT—duodenum cancer	0.00215	0.00215	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—GAST—duodenum cancer	0.00207	0.00207	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SCT—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—GAST—duodenum cancer	0.00205	0.00205	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.002	0.002	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SCT—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—SST—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—SST—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—SST—duodenum cancer	0.00195	0.00195	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SCT—duodenum cancer	0.00194	0.00194	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—SST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00191	0.00191	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—MEN1—duodenum cancer	0.00188	0.00188	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—MEN1—duodenum cancer	0.0018	0.0018	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—SST—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—SST—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00177	0.00177	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—SST—duodenum cancer	0.00177	0.00177	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—SST—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00172	0.00172	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.0017	0.0017	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—MEN1—duodenum cancer	0.0017	0.0017	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00168	0.00168	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00161	0.00161	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—SST—duodenum cancer	0.00158	0.00158	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—GAST—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—SST—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00154	0.00154	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—GAST—duodenum cancer	0.00154	0.00154	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—GAST—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—GAST—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—GAST—duodenum cancer	0.00151	0.00151	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.00151	0.00151	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—SST—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SCT—duodenum cancer	0.00148	0.00148	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00147	0.00147	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SCT—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SCT—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SCT—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SCT—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00143	0.00143	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—SST—duodenum cancer	0.00142	0.00142	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.00141	0.00141	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—SST—duodenum cancer	0.0014	0.0014	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.0014	0.0014	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.00133	0.00133	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.0013	0.0013	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00128	0.00128	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MEN1—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MEN1—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MEN1—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MEN1—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00122	0.00122	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.00116	0.00116	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.00116	0.00116	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SST—duodenum cancer	0.00107	0.00107	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SST—duodenum cancer	0.00106	0.00106	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SST—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SST—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SST—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SST—duodenum cancer	0.00104	0.00104	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.00103	0.00103	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.000961	0.000961	CbGpPWpGaD
